Novartis to streamline production in response to lower U.S. prices: NZZ am Sonntag

Switzerland's Novartis (NOVN.S) plans to streamline its worldwide production to increase its operating profit margin despite falling prices for its drugs in the United States, its chairman was reported as saying.